Triple combination of pegylated interferon alpha 2b, ribavirin and amantadine for treatment of chronic hepatitis

被引：0
|
作者：
Younossi, ZM
McCullough, AJ
Barnes, DS
Post, A
Ong, JP
Mullen, KD
Carey, WD
O'Shea, R
Levinthal, G
Gramlich, T
Martin, LM
Bringman, D
Tavill, A
Ferguson, R
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83944-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A781 / A781
页数：1
相关论文
共 50 条
  • [41] Interferon-α-2b/pegylated interferon and ribavirin treatment in renal disease with renal insufficiency and chronic hepatitis C infection
    Bruchfeld, A
    Lindahl, K
    Schvarcz, R
    Ståhle, L
    ANTIVIRAL THERAPY, 2002, 7 (04) : L127 - L127
  • [42] A randomized trial of pegylated interferon α-2b plus ribavirin in the retreatment of chronic hepatitis C
    Jacobson, IM
    Gonzalez, SA
    Ahmed, F
    Lebovics, E
    Min, AD
    Bodenheimer, HC
    Esposito, SP
    Brown, RS
    Bräu, N
    Klion, FM
    Tobias, H
    Bini, EJ
    Brodsky, N
    Cerulli, MA
    Aytaman, A
    Gardner, PW
    Geders, JM
    Spivack, JE
    Rahmin, MG
    Berman, DH
    Ehrlich, J
    Russo, MW
    Chait, M
    Rovner, D
    Edlin, BR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2453 - 2462
  • [43] Daily administration of interferon alpha 2b and utility of combination therapy with ribavirin as initial treatment for chronic hepatitis C.
    Ricchiuti, A
    Ciccorossi, P
    Costa, F
    Bellini, M
    Carrara, PD
    Arpe, P
    Maggi, F
    Vatteroni, ML
    Bendinelli, M
    Maltinti, G
    Marchi, S
    HEPATOLOGY, 1999, 30 (04) : 627A - 627A
  • [44] Treatment of acute hepatitis C with pegylated interferon alpha-2b and ribavirin
    Capozza, TA
    Brann, OS
    Coyle, WJ
    Schindler, WR
    BeMiller, TA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S188 - S188
  • [45] The role of triple therapy (interferon, ribavirin and amantadine) in the treatment of chronic hepatitis C.
    Vlodov, J
    Charania, M
    Jose, RM
    Iswara, K
    Lapin, S
    Terebelo, S
    Bernstein, M
    Tenner, S
    HEPATOLOGY, 2000, 32 (04) : 565A - 565A
  • [46] Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis
    Derbala, M
    Amer, A
    Bener, A
    Lopez, AC
    Omar, M
    El Ghannam, M
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (04) : 380 - 385
  • [47] Efficacy and tolerability of pegylated interferon alpha-2a plus ribavirin versus pegylated interferon alpha-2b plus ribavirin, in treatment naive chronic hepatitis C patients
    Lee, S. Y.
    Lee, S.
    Ko, K. S.
    Kim, I. H.
    Kim, S. H.
    Kim, S. W.
    Lee, S. O.
    Lee, S. T.
    Kim, D. G.
    Choi, C. S.
    Cho, E. Y.
    Kim, H. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176
  • [48] Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment
    Baek, Yang Hyun
    Lee, Sung Wook
    Yoo, Hyun Seung
    Yoon, Hyun Ah
    Kim, Ja Won
    Kim, Young Hoon
    Kim, Ha Youn
    Han, Sang Young
    GUT AND LIVER, 2007, 1 (01) : 87 - 89
  • [49] Investigation of hyperuricemia during pegylated-interferon-α2b plus ribavirin combination therapy in patients with chronic hepatitis C
    Yamashita, Naoki
    Enjoji, Munechika
    Kotoh, Kazuhiro
    Kato, Masaki
    Ueda, Akihiro
    Horikawa, Yuki
    Tajiri, Hirotaka
    Higuchi, Nobito
    Kinukawa, Naoko
    Nakamuta, Makoto
    Takayanagi, Ryoichi
    JOURNAL OF DIGESTIVE DISEASES, 2008, 9 (01) : 27 - 31
  • [50] Combination therapy with pegylated interferon-A 2b and ribavirin in naive patients with chronic hepatitis C virus inection.
    Kallinowski, B
    Engler, S
    Bauer, E
    Stremmel, W
    Rossol, S
    HEPATOLOGY, 2002, 36 (04) : 580A - 580A
12345